Cargando…

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients

BACKGROUND: Analytical treatment interruptions (ATIs) are essential in research on HIV cure. However, the heterogeneity of virological outcome measures used in different trials hinders the interpretation of the efficacy of different strategies. METHODS: We conducted a retrospective analysis of viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fehér, Csaba, Leal, Lorna, Plana, Montserrat, Climent, Nuria, Crespo Guardo, Alberto, Martínez, Esteban, Castro, Pedro, Díaz-Brito, Vicens, Mothe, Beatriz, López Bernaldo De Quirós, Juan Carlos, Gatell, Josep María, Aloy, Patrick, García, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047957/ https://www.ncbi.nlm.nih.gov/pubmed/32128329 http://dx.doi.org/10.1093/ofid/ofz485

Ejemplares similares

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
por: Leal, Lorna, et al.
Publicado: (2020)

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B
por: Couto, Elvira, et al.
Publicado: (2019)

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes
por: Sued, Omar, et al.
Publicado: (2015)

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
por: Guardo, Alberto C., et al.
Publicado: (2018)

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
por: C. Guardo, Alberto, et al.
Publicado: (2017)

Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis
por: Spinelli, Matthew A, et al.
Publicado: (2022)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
por: Rosás-Umbert, Miriam, et al.
Publicado: (2017)

Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals
por: Guardo, Alberto Crespo, et al.
Publicado: (2013)

Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
por: Climent, Núria, et al.
Publicado: (2019)

Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals
por: Fehér, Csaba, et al.
Publicado: (2021)

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
por: Torres, Berta, et al.
Publicado: (2014)

Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Cellular immune responses and changes in VL after a Dendritic Cells (DC)-based therapeutic vaccine in cART treated chronic HIV-infected patients with CD4 T cells above 450/mm
por: García, F, et al.
Publicado: (2012)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
por: Leal, Lorna, et al.
Publicado: (2018)

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
por: Leal, Lorna, et al.
Publicado: (2021)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center
por: Yoke, Leah H, et al.
Publicado: (2021)

Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
por: Hakre, Shilpa, et al.
Publicado: (2022)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults
por: Simons, Lacy M, et al.
Publicado: (2022)

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks
por: Rolle, Charlotte-Paige, et al.
Publicado: (2023)

Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review
por: Llibre, Josep M, et al.
Publicado: (2022)

The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis
por: Kitano, Taito, et al.
Publicado: (2021)

Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression
por: Vitallé, Joana, et al.
Publicado: (2017)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
por: Young, Jim, et al.
Publicado: (2017)

Unsatisfactory long-term virological suppression in human immunodeficiency virus-infected children in the Amazonas State, Brazil
por: Pacheco, Ana Luisa Opromolla, et al.
Publicado: (2020)

Generation and Characterization of a Defective HIV-1 Virus as an Immunogen for a Therapeutic Vaccine
por: Álvarez-Fernández, Carmen, et al.
Publicado: (2012)

Employee Reactions to Interruptions from Family during Work
por: Horvath, Michael, et al.
Publicado: (2021)

Results of Early Virologic Monitoring May Facilitate Differentiated Care Monitoring Strategies for Clients on ART, Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2018)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis
por: Kabra, Madhusudan, et al.
Publicado: (2023)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus
por: Weijsenfeld, Annouschka M, et al.
Publicado: (2022)

In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
por: Esteban, Ignasi, et al.
Publicado: (2021)

Clinical and Ecological Impact of an Educational Program to Optimize Antibiotic Treatments in Nursing Homes (PROA-SENIOR): A Cluster, Randomized, Controlled Trial and Interrupted Time-Series Analysis
por: Peñalva, Germán, et al.
Publicado: (2022)

Randomized Controlled Pilot Study of Antiretrovirals and a Behavioral Intervention for Persons With Acute HIV Infection: Opportunity for Interrupting Transmission
por: Miller, William C, et al.
Publicado: (2018)

Quantification and Progress Over Time of Specific Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in Breast Milk of Lactating Women Vaccinated With BNT162b2 Pfizer-BioNTech Coronavirus Disease 2019 Vaccine (LacCOVID)
por: Esteve-Palau, Erika, et al.
Publicado: (2022)

Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets
por: Boullé, Charlotte, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u77359bcbab1ik47vhl36c8m2l